바이오테크 보도자료
-
- Semperis Strengthens Active Directory Protection in the Asia-Pacific Market with Expansion Plans Accelerated by Strategic Channel Appointment
- Semperis, the pioneer in identity-driven cyber resilience for enterprises accelerated expansion of its hybrid identity protection solutions in the Asia-Pacific region by bringing onboard Jacquie Young, a lea...
- 2022년 08월 11일
-
- SMART Modular Announces SMART Zefr Memory with Ultra-High Reliability Performance for Demanding Compute Applications
- SMART Modular Technologies, Inc. (“SMART”), a division of SGH (Nasdaq: SGH) and a global leader in memory solutions, solid-state drives, and hybrid storage products announces its SMART Zefr™ Memory, a propri...
- 2022년 08월 10일
-
- Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic
- Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) will hold a meeting on September 22, 2022,...
- 2022년 08월 10일
-
- Kirin Holdings’ Long-term GHG Reduction Target Was Approved by the Science Based Targets[*1] Initiative Based on Science-based Net-zero Targets
- Kirin Holdings Company, Limited (Kirin Holdings) has been approved as the first world company in the food and beverage processing sector with science-based net-zero targets validated by SBTi [*2] in July 202...
- 2022년 08월 08일
-
- GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution
- Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel grou...
- 2022년 08월 05일
-
- First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
- Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continued to increase its supply of medicine to patients in the first half of 2022, as it expanded its research pipeline in an incre...
- 2022년 08월 04일
-
- SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
- Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that based on related clinical trials and studies of vaccination for loca...
- 2022년 08월 04일
-
- Graminex®, L.L.C. Completes Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence with Positive Results.
- Graminex®, L.L.C. is pleased to announce it has completed a clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health with positive results. This study was condu...
- 2022년 08월 02일
-
- Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Management Guidance
- Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for the first quarter of fiscal year 2022 (period ended June 30, 2022) and is on track to meet its full-year management guidance. The gai...
- 2022년 07월 29일
-
- Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate
- Organon (NYSE: OGN), a global women’s healthcare company, and Cirqle Biomedical today announced they have entered into a research collaboration and exclusive license agreement for a novel investigational non...
- 2022년 07월 29일
-
- PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments
- PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced a significant expansion of its world-class facility in Tredegar, Wales, UK, designed to...
- 2022년 07월 28일
전시회
